(Press-News.org) Dr. Vanessa Bellat, an assistant professor of chemistry in radiology and an affiliate of the Molecular Imaging Innovations Institute (MI3) at Weill Cornell Medicine, has been awarded a $2 million, four-year R37 MERIT grant from the National Cancer Institute, part of the National Institutes of Health. She will be developing a new therapeutic approach using nanofibers that selectively deliver drugs to the lungs to treat metastatic tumors and testing it in preclinical models. These fibers are made from peptide chains (building blocks that make up proteins) and have a unique 2-dimensional single layer structure that can carry imaging agents and therapeutics.
“I am excited to receive this very competitive grant which allows me to follow my passion for nanotechnology. I believe in the huge potential of nanofibers to revolutionize drug delivery for not only cancer, but other diseases as well,” Dr. Bellat said. “There’s a lot of work to do before bringing it to patients, so this support, which can be extended an additional two years, will help me push this research forward.”
The MERIT program, a backronym for “Method for Extending Research In Time,” gives highly accomplished and promising early career investigators longer-term grant support.
Treating Cancer While Sparing Healthy Cells
Dr. Bellat is focusing on tumors that originated from triple-negative breast cancer and spread to the lungs. Currently, there are no effective treatments for such metastatic lung tumors, which are highly aggressive, complex and genetically diverse. Chemotherapy which kills any fast-growing cells in the body—both healthy and cancerous—is used in clinics in palliative care to prolong a patient’s life, but with severe side effects. Alternative proposed treatments such as targeted therapy and immunotherapy have also failed to successfully treat lung metastases, since these treatments don’t last at the tumor site and often accumulate in off-target organs.
To address the need for improved precision drug-delivery systems that reduce off-target effects, Dr. Bellat’s lab is designing peptide-based nanofibers (pNFP6) that can specifically target and accumulate at the organ of interest. She is using this approach to deliver chemotherapeutic drugs directly to metastatic lung tumors without affecting the rest of the body. The lung-targeting nanofibers are about 10,000 nanometers long, 5 nanometers wide and the thickness is negligible. In comparison, a strand of human hair is 80,000 - 100,000 nanometers wide.
Using pNFP6 for drug delivery is innovative as multiple nanofibers can self-assemble into a large, interconnected network (interfibril) that stays in the lungs, releasing a broad-spectrum of anticancer drugs over time and providing a long-term treatment. The nanofibers are eventually processed by the liver and eliminated from the body much like other drugs. Dr. Bellat’s lab is using the peptide-based nanofiber drug delivery technology in combination with radiation therapy to directly kill cancer cells and activate the body’s immune system. Together, the two approaches could cooperatively and synergistically stop disease progression to provide a more effective treatment.
Tracking Drug Delivery in Real Time
For proof-of-principle studies, Dr. Bellat’s lab will optimize the structure of the nanofibers to carry and release the drug doxorobucin (Dox) only when they reach the tumor microenvironment, which avoids harming healthy tissue. The researchers will also assess the therapeutic efficacy (tumor inhibition and survival benefit) and the toxicity profile of this combination therapy in preclinical models bearing metastatic lung tumors. They can track drug delivery, release and tumor uptake in real time using multiple imaging and microscopic techniques.
“The physical and chemical properties of the nanofibers can be fine-tuned including the size, shape, ability to dissolve in water and surface charges. In doing so, we can control the targeting and retention profile of the nanofibers to treat other cancers, which we are also working on, such as bladder and kidney cancers,” Dr. Bellat said.
For this research, Dr. Bellat will be collaborating with Dr. Benedict Law, associate professor of pharmacology in radiology at Weill Cornell Medicine, and Dr. Claire Vanpouille-Box, assistant professor of cell biology in radiation oncology at Weill Cornell Medicine.
NIH awards merit grant for nanofiber research targeting metastatic lung tumors
ELSE PRESS RELEASES FROM THIS DATE:
UTA research: Wildlife loss five times slower in protected areas
Protecting large areas of land from human activity can help stem the tide of biodiversity loss, especially for vertebrates like amphibians, reptiles, mammals and birds, according to a new study in Nature. In particular, vertebrate population declines were five times slower in conservation areas compared to animals living in areas not protected from development or conversion to agricultural use. “Protected areas take us from a situation in which biodiversity is ebbing away to one where populations are at least close to stable,” said Luke Frishkoff, coauthor of the study and assistant professor of biology at The University of Texas at Arlington. ...
Milestone for novel atomic clock
An international research team has taken a decisive step toward a new generation of atomic clocks. At the European XFEL X-ray laser, the researchers have created a much more precise pulse generator based on the element scandium, which enables an accuracy of one second in 300 billion years – that is about a thousand times more precise than the current standard atomic clock based on caesium. The team presents its success in the journal Nature. Atomic clocks are currently the world’s ...
NSF backs Rice processor design, chip security research
HOUSTON – (Sept. 27, 2023) Rice University computer scientists have won two grants from the National Science Foundation to explore new information processing technologies and applications that combine seamlessly co-designed hardware and software to allow for more effective and efficient data stream analysis using pattern matching. Initiated by a Rice seed grant, the projects address the limitations of current computing infrastructure’s ability to process complex, unstructured data streams. A $1.2 million award will ...
St. Jude Children’s Research Hospital unveils the Domino’s Village
MEMPHIS, Tenn., Sept. 27, 2023 – St. Jude Children’s Research Hospital® and Domino’s®, the largest pizza company in the world, today unveiled The Domino’s Village, a multi-million dollar housing facility for patients and their families. The six-story building that provides more than 307,000 square feet of residential and recreational space was funded by Domino’s as part of a 10-year, historic $100 million commitment to St. ...
U of M Medical School professor receives $3.5 million to develop Tanzanian reproductive health curriculum for those with disabilities
MINNEAPOLIS/ST. PAUL (09/27/2023) — Kristen Mark, PhD, with the University of Minnesota Medical School, received a $3.5 million grant from the National Institutes of Health to enhance the quality of life for individuals with disabilities in Tanzania through a new project. The research team will train future healthcare providers like nurses, doctors and midwives with the skills and confidence to offer comprehensive sexual and reproductive healthcare services for people with disabilities. “Through doing this research, we will improve the lives of people with disabilities in Tanzania and build in-country capacity ...
How liver cells become scarring, and worse
Hepatic fibrosis occurs when scar tissue replaces damaged cells in the liver. Over time, accumulating scarring distorts the liver, interferes with its blood supply and may progressively lead to worsening consequences, from cirrhosis to liver failure to liver cancer. In advanced cases, the only treatment is an organ transplant. In a new paper, published online in the journal Cellular and Molecular Gastroenterology and Hepatology, a team of scientists led by corresponding authors David A. Brenner, ...
Does form follow function? Johns Hopkins Medicine researchers advance understanding of why cell parts look the way they do
Scientists have long understood that parts of cells, called organelles, evolved to have certain shapes and sizes because their forms are closely related to how they function. Now, Johns Hopkins researchers have developed a bacteria-based tool to test whether, as the axiom goes, form follows function. The tool, which researchers say may someday have practical applications in treating illness, works by precisely targeting and dismantling the outer membrane surrounding organelles, and is being made freely available to other scientists. In an interesting twist, say the researchers, the tool may also be able to dismantle aggregated proteins in cells that ...
New study finds children of color and from low-income families are exposed to more toxic chemicals and experience greater harm
Media contacts: Abby Manishor email@example.com Allison Eatough firstname.lastname@example.org EMBARGOED FOR RELEASE UNTIL Wednesday, September 27, 2023 at 12:01am ET New Study Finds Children of Color and from Low-Income Families Are Exposed to More Toxic Chemicals and Experience Greater Harm Landmark research review is the first to examine disparities in neurotoxic exposures and the harmful effects of those exposures on children by race, ethnicity, and economic status WASHINGTON, D.C., September 27, 2023—Children from families with low incomes and families of color are exposed to more neurotoxic ...
Community mobility and depressive symptoms during the pandemic
About The Study: Depressive symptoms were greater in locales and times with diminished community mobility in this survey study with 192,000 respondents. Strategies to understand the potential public health consequences of pandemic responses are needed. Authors: Roy H. Perlis, M.D., M.Sc., of Massachusetts General Hospital in Boston, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2023.34945) Editor’s ...
Cannabis use frequency and cannabis-related consequences in high-risk young adults across cannabis legalization
About The Study: In a study of 619 high-risk young adults in Ontario, Canada, individuals using cannabis frequently pre-legalization showed significant reductions in use and consequences over time, reflecting an aging out pattern. Small increases in use among participants with no pre-legalization use were observed over time, but without parallel changes in cannabis-related consequences. The results did not reveal substantive adverse near-term outcomes across the legalization period, although a within-participants design cannot rule out the possibility of alternative trajectories in the absence of legalization. Authors: Amanda Doggett, ...